Kai Li

机构：Sun Yat-sen University, China West Normal University, Capital Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Sichuan University, Nanjing Drum Tower Hospital, Third Affiliated Hospital of Sun Yat-sen University, Tongji Hospital, University of Chinese Academy of Sciences, Huazhong University of Science and Technology, Nanjing Medical University

发表论文 23 篇 · 总被引 221 次 · h-index 7

代表论文

• First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial (2024 · The Lancet Respiratory Medicine · 被引 58)
• Significant CircRNAs in liver cancer stem cell exosomes: mediator of malignant propagation in liver cancer? (2023 · Molecular Cancer · 被引 39)
• RETRACTED ARTICLE: Protective role of arachidonic acid against diabetic myocardial ischemic injury: a translational study of pigs, rats, and humans (2024 · Cardiovascular Diabetology · 被引 22)
• The PI3K/Akt/mTOR Pathway: Immuno-Metabolic Orchestration in IR/MASH-Associated Hepatocellular Carcinoma (2025 · International Journal of Biological Sciences · 被引 21)
• Efficacy, safety and pharmacokinetics of Unecritinib (TQ-B3101) for patients with ROS1 positive advanced non-small cell lung cancer: a Phase I/II Trial (2023 · Signal Transduction and Targeted Therapy · 被引 18)
• Thermal ablation with and without adjuvant systemic therapy: a nationwide multicenter observational cohort study of solitary colorectal liver metastases (2024 · International Journal of Surgery · 被引 8)